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Changes in cell adhesion, regulated by environmental signals such
as growth factors, appear to be necessary for dynamic cellular
movement and maintenance of tissue patterning. E-cadherin is
well-established as playing a suppressive role in the progression of
malignant disease (Takeichi, 1991). Selective reduction or loss of
E-cadherin is correlated not only with dedifferentiation, but also
with the invasive phenotype in vitro and in vivo (Birchmeier et al,
1993; Pignatelli et al, 1992). This has been reported in pancreatic
carcinoma, where loss of membranous E-cadherin correlated with
high grade and advanced tumour stage (Pignatelli et al, 1994).
Furthermore, the role of E-cadherin in tumour progression has
been explored using specific inhibitors and gene transfer experi-
ments. Transfection of E-cadherin-negative colorectal carcinoma
cells with E-cadherin cDNA restores not only their capacity for
intercellular adhesion but also results in reversal of the invasive
phenotype (Liu et al, 1993). 
A growing body of evidence suggests a role for the FGF/FGFR
system in the modulation of cell adhesion and cell migration. It has
been demonstrated that neurite outgrowth responses stimulated by
cell adhesion molecules (CAMs) are mediated via FGFR, prob-
ably as a direct consequence of an interaction via the CAM
homology domain (Doherty et al, 1995). FGFR-CAM interaction
was further substantiated by identifying and characterizing a CAM
homology domain (CHD) within the extracellular domains of
FGFR, with similarity to regions found in L1, NCAM (VASE
motif) (Williams et al, 1994) and N-cadherin (HAV motif) (Byers
et al, 1992). These regions in CAMs have been implicated in the
mediation of homophilic interactions between cadherin molecules.
Subsequently, anti-FGFR antibodies and CHD peptides were both
shown to inhibit neurite outgrowth responses to cell adhesion
molecules and FGF-2 (Doherty et al, 1995). 
Finally, indirect evidence comes from observations that the
expression levels and/or functions of growth factor receptor tyro-
sine kinases (RTK) and E-cadherin may be co-ordinated. In this
context, b-catenin has been shown to associate with at least two
receptor tyrosine kinases: epidermal growth factor receptor
(EGFR) (Hoschuetzky et al, 1994) and c-erB-2 (Kanai et al, 1995).
Ligand-induced activation of these receptors also results in
increased tyrosine phosphorylation of b-catenin and subsequent
impaired cadherin/catenin function by a mechanism that is still
poorly understood. 
We have examined the possible involvement of E-cadherin in
determining the invasive phenotype of pancreatic carcinomas and
investigated whether E-cadherin functions can be modulated by
stimulation with exogenous FGF-1 and FGF-2 in a panel of human
pancreatic adenocarcinoma cell lines that express different combi-
nations of FGFRs. 
MATERIALS AND METHODS 
Cell lines 
Human pancreatic adenocarcinoma cell lines that express various
combinations of FGFRs (Leung et al, 1994) and exhibit differ-
ent  grades of differentiation were used. The BxPc3 cell line
(American Type of Culture Collection (ATCC), Rockville,
Maryland) is a moderately to well differentiated cell line derived
from a primary tumour (Tan et al, 1986) and expresses FGFR-1;
the T3M4 cell line is a moderately differentiated cell line, which
was derived from a lymph node metastasis (Okabe et al, 1983) and
expresses FGFR-3; and the HPAF cell line which is a moderately
to poorly differentiated cell line that was derived from ascitic fluid
(Metzgar et al, 1982) and is FGFR-3 and FGFR-4 positive. All cell
lines were maintained in standard medium. 
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Growth factors and antibodies 
Human recombinant FGF-1 and FGF-2 (Upstate Biotechnology,
Lake Placid, NY, USA) were used for stimulation of the cell lines at
various concentrations between 1 ng/ml and 50 ng/ml. Heparin was
added at 10 mg/ml and 1 mg/ml with FGF-1 and FGF-2, respectively,
as shown to be suitable for FGFR activation by FGFs in this tissue
type (Leung et al, 1994). 
The mouse monoclonal anti-human E-cadherin antibody, HECD-
1, was kindly provided by Prof. Takeichi (Kyoto University, Kyoto,
Japan). Mouse monoclonal anti-human E-cadherin, a-,  b-and  g-
catenin antibodies were purchased from Transduction Laboratories,
Exeter, UK. The monoclonal anti-Ep-CAM (AUA-1) and anti-CEA
(PR3B10) antibodies were kindly provided by Sir Walter Bodmer
(ICRF). The anti-FGFR antibodies used in the study were anti-
FGFR-1 antibodies (8E10 (Prizm Pharmaceuticals) and VBS6
(Santa Cruz)). Anti-phosphotyrosine antibody 4G10 was purchased
from Upstate Biotechnology. 
Cell–cell adhesion assay 
Cells were grown to 90% confluence, washed twice in PBS, and
subsequently treated with 2 mM EDTA for 10 min at 37˚C.
Detached cells were washed once with RPMI medium and were
passed through Pasteur pipettes several times to obtain single cells.
Cells were then re-suspended in either Ca2+-free PBS/0.8% FCS or
RPMI/0.8% FCS (controls). In FGF stimulation experiments,
FGF-1 or FGF-2 was added to the medium at concentrations of 1,
5, 10, 20, and 50ng/ml at the time of initiation of the assay. Cells
were then inoculated at 5´105 cells/ml into 24-well plates
(500ml/well) that had been coated overnight with 1% (w/v) bovine
serum albumin in PBS to prevent non-specific cell adhesion to
wells. Cells were allowed to aggregate for 1 h at 37˚C on a gyra-
tory shaker with constant rotation at 90 rpm. Cell aggregation was
terminated by the addition of 4% (w/v) glutaraldehyde fixative to
individual wells at 0, 15, 30, 45 or 60 min. Aliquots were taken at
each time point and the number of single cells was then deter-
mined with a Coulter counter (Coulter Electronics, Inc.). Cell-cell
adhesion was assessed by the cell aggregation index (Nt/NO),
where Nt is the number of single cells after the incubation time,
and NO is the number of single cells at the initiation of the assay. 
Blocking of E-cadherin-mediated cell adhesion 
Experiments were carried out as above except that cell suspen-
sions were incubated with 10 mg/ml anti-E-cadherin (HECD-1)
antibody for 30 min before the initiation of the assay. The extent of
inhibition of cell adhesion was represented as percent inhibition
(Ni/Nc X 100%), where Ni is the number of single cells in the
presence of anti-E-cadherin antibody and Nc is number of single
cells in the absence of the antibody (control). 
In vitro invasion system in collagen gel 
Collagen gels were prepared by mixing eight volumes of ice-
cold collagen type I stock solution (Vitrogen 100, Imperial
Laboratories, UK) with one volume of 10X DMEM containing
phenol red indicator and neutralised with 0.1 M NaOH. Aliquots
(1 ml) were added into 35 mm tissue culture dishes and incubated
for 1 h at 37˚C in a 10% CO2 incubator. After gelation, 1X105
cells re-suspended in 1 ml of RPMI/1% FCS alone (control) or
supplemented with FGF-1 or FGF-2 (1, 5, 10, or 20 ng/ml) were
seeded onto the gel. Cells were re-fed every 3 days for 10 days
with the standard medium alone (control) or supplemented with
FGF, and growth was assessed daily using a phase contrast micro-
scope. Gels were finally fixed in 10% formaldehyde overnight,
paraffin embedded, serially sectioned in vertical orientation (5 mm
sections), stained with haematoxylin and eosin and photographed.
The number of cells that invaded the gel in 10 randomly selected
graticule areas from duplicate cultures was determined. The
degree of invasion was represented by the invasion index (Nv/Nc),
where Nv is the number of invading cells in stimulated cultures
and Nc is the number of invading cells in control cultures. In some
experiments, serial dilutions of monoclonal anti-E-cadherin
(HECD-1), anti-CEA and anti-EP-CAM antibodies were added to
the culture medium for five consecutive days. Purified mouse
immunoglobulins (50mg/ml) were also used as control in these
experiments. 
Morphogenic assay in 3-D collagen gels 
Experiments were carried out as above except that 1ml of the
single cell suspension was mixed with 10 volumes of the neutral-
ized vitrogen solution to yield a final concentration of 1´105
cells/ml, and the solution was allowed to gel at 37˚C. Gels were
then overlaid with the standard medium alone (control) or medium
supplemented with FGF-1 or FGF-2 (10 ng/ml), that was replaced
every 4 days for 21 days. Plates were checked daily for the appear-
ance of glandular structures using a phase-contrast microscope. 
Immunohistochemistry 
Sections prepared from the morphogenic assay were deparaf-
finized in xylene and rehydrated in graded alcohols. An avidin-
biotin peroxidase method was applied. Tris-buffered saline (TBS)
was used in all washing steps. Non-specific binding was blocked
with normal rabbit serum, and sections were probed with opti-
mally diluted primary antibody for 2 h, washed, and then incu-
bated with biotinylated rabbit anti-mouse antibody (Dakopatts,
Denmark; 1:200) for 30 min, followed by freshly prepared avidin-
biotin-peroxidase complex (ABC) for 30 min. Sections were
developed in 0.05% (w/v) diaminobenzidine (DAB) and 0.03%
(v/v) hydrogen peroxide in PBS, counterstained in haematoxylin
and mounted. As a negative control, the primary antibody was
replaced by TBS. The sections were assessed for the subcellular
localisation of E-cadherin and catenins (membranous, cyto-
plasmic, mixed membranous and cytoplasmic). The staining inten-
sity of E-cadherin and catenins were also graded semiquantitatively
using an arbitrary scale of intensity: – (no expression); + (increased
expression); and +/– (equivocal expression). 
Immunoprecipitation and immunoblotting 
These experiments were performed as previously described (El-
Hariry et al, 1999). Briefly, cell lysates (soluble fraction) were
precleared and incubated with anti-E-cadherin, anti-a-, anti-b-,
and anti-g-catenin antibodies overnight at 4˚C with rotation.
Immune-complexes were precipitated with 50 ml/ml protein 
G-sepharose, and the immunoprecipitates were resolved by 
SDS-PAGE and transferred onto nitrocellulose membranes
(Millipore, Herts, UK) for immunoblotting. After non-specific
binding was blocked, membranes were probed overnight with: 1658 I EI-Hariry et al
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(i) anti-E-cadherin (1 mg/ml); (ii) anti-b-catenin, 1 mg/ml; (iii) anti-
a-catenin, 4 mg/ml and (iv) anti-g-catenin, 1 mg/ml. Membranes
were incubated with peroxidase-conjugated secondary anti-mouse
antibodies (Dako Ltd, Bucks, UK; 0.5 mg/ml) for 2 h at room
temperature, washed, and then were reacted with enhanced chemi-
luminescence reagent (ECL; Amersham Life Sciences, Bucks,
UK) and exposed to Hyperfilm-MP film (Amersham Life
Sciences, Bucks, UK). Cell lysates immunoprecipitated with IgG
were used as a control for the antibody specificity. 
The protein levels were assessed by densitometric analysis
using ImageQuant image analysis software package (Molecular
Dynamics, Inc, Bucks, UK). Results were presented in arbitrary
units of the integrated optical density (OD). All experiments were
repeated twice. 
Statistical analysis 
Where the effect of either FGF-1 or FGF-2 was compared to the
control samples, the significance of differences between groups was
calculated by the Student’s two-tailed t-test. The mean and the stan-
dard deviation (SD) were calculated from at least three separate
experiments. The effect of FGF-1 and FGF-2 on cell-cell adhesion
as a function of FGF doses was computed using the analysis of vari-
ance (F-test) to compare the difference between control, FGF-1 and
FGF-2. The level of significance was taken as P < 0.05. 
RESULTS 
Cell-cell adhesion in pancreatic cell lines 
In the absence of Ca2+, all pancreatic cell lines showed poor spon-
taneous aggregation, but they readily formed cell aggregates in the
presence of Ca2+. The increase in cell aggregation was small 
but statistically significant. This finding indicated that cell-cell
adhesion was mediated by a Ca2+-dependent mechanism. Since
this aggregation was significantly blocked by the addition of the
monoclonal anti-E-cadherin antibody (HECD-1), it was apparent
that E-cadherin was the most likely candidate implicated in cell-
cell adhesion and was functionally active in these cell lines. As
additional controls, incubation with anti-CEA and anti-EP-CAM
antibodies did not block cell-cell adhesion in Ca2+-supplemented
cell suspension (RPMI medium), thus giving further evidence for
the specificity of E-cadherin-mediated effects. 
Both FGFs significantly increased cell aggregation in BxPc3 (P
< 0.01), T3M4 (P < 0.001) and HPAF cell lines (P < 0.001) only in
the presence of Ca2+, Figure 1(A-C). FGFs appeared to modulate
the kinetics of the cell-cell adhesion. For instance, in HPAF cells,
while half-maximal aggregation was not reached until 55 min in
untreated cells, it occurred within ~15 min in cells treated with
FGF-2 and FGF-1, Figure 1C. Furthermore, cell aggregates
appeared large and coalescent in the presence of FGF-1 or FGF-2
as opposed to small and irregular aggregates in untreated cells. 
The modulation of cell-cell adhesion by FGFs was E-cadherin-
dependent, since anti-E-cadherin antibody inhibited the effect of
FGF-1 and FGF-2 on cell-cell adhesion almost completely in the
three cell lines, Figure 1D. In contrast, the modulatory effect of
FGF-1 or FGF-2 was not blocked by the treatment of cell suspen-
sions with anti-CEA and anti-EP-CAM antibodies in Ca2+-supple-
mented or Ca2+-free medium. The effect of FGF-1 and FGF-2 on
cell-cell adhesion is dose-dependent in the range of 1 ng/ml to 
20 ng/ml, which was statistically significant, Figure 1E. 
In vitro invasion into collagen gel 
The cell lines used in the current study varied in their migratory
ability through the gel matrix. Figure 2 depicts the effect of
FGF-1 and FGF-2 on the invasive behaviour of these cell lines.
Both BxPc3 and T3M4 cell lines grew into the gel front as solid
sheets or as confluent irregular islands of cells, and exhibited a
weak to moderate invasive capacity. FGF-treated cells became
more cohesive and less invasive. HPAF cells assumed a pleo-
morphic appearance and were markedly invasive. In the pres-
ence of FGF-1 or FGF-2, cells became more cohesive than
control untreated cultures and less invasive into the collagen.
The effect of FGFs was demonstrated at concentrations as low
as as 1 ng/ml and up to 20 ng/ml. The effect of FGF was E-
cadherin-mediated, since it was abrogated by treatment with
HECD-1 antibody, but not with anti-CEA, anti-EP-CAM anti-
bodies or purified mouse IgG. 
Morphogenic assay in 3-D collagen gels 
Stimulation with FGF-1 or FGF-2 did not produce any discernible
effects on morphogenesis in either BxPc3 or T3M4 cells. In
contrast, both FGF-1 and FGF-2 induced glandular differentiation
in HPAF cells, where organised structures consisting of a single
layer of cells with basally arranged nuclei around a central lumen
were observed, Figure 3. 
FGFs increase tyrosine phosphorylation of 
E-cadherin/catenin system 
In addition, tyrosine phosphorylation of E-cadherin and catenins
was examined. Serum-starved cells were treated with medium
alone or supplemented with either FGF-1 or FGF-2 for 15 min.
Lysates were immunoprecipitated with anti-E-cadherin, anti-
a-catenin, anti-b-catenin or anti-g-catenin antibodies, separated
by SDS-PAGE, and the immunoblots were probed with anti-
phosphotyrosine antibody. Figure 4 depicts the tyrosine phospho-
rylation of E-cadherin and catenins in control and FGF-stimulated
cells. Both FGF-1 and FGF-2 induced approximately 2-fold
increase in the tyrosine phosphorylation of E-cadherin in BxPc3
cells (Figure 4A, lanes 2 and 3), as compared to 3-fold and 6-fold
increase in HPAF cells respectively, Figure 4A, lanes 8 and 9.
Similarly, both FGFs induced an approximately 2-fold increase in
tyrosine phosphorylation of b-catenin in both cell lines (Figure
4C, lanes 2, 3, 8 and 9), and a-catenin in only HPAF cells, Figure
4B, lanes 8 and 9. While both FGFs produced an increase in tyro-
sine phosphorylation of b-catenin (Figure 4C, lane 5), they had
only a marginal effect on E-cadherin, a-catenin, or g-catenin in
T3M4 cells. 
FGFs upregulate the expression of E-cadherin and
catenins 
Formalin-fixed, paraffin-embedded sections of the control and
FGF-treated cells were stained with anti-E-cadherin, anti-a, anti-
b-and anti-g-catenin antibodies. As shown in Table 1, both FGF-1
and FGF-2 up-regulated the expression of E-cadherin and/or one
or more of the catenins. The immunoreactivity of E-cadherin
(Figure 5A), b-catenin (Figure 5B) and g-catenin was restricted to
membranous localisation on FGF stimulation. Physical association of FGFs and E-cadherin/catenin 
We next examined the possibility of a physical association
between the E-cadherin/catenin and FGFR systems. E-
cadherin/catenin complexes from confluent cultures of BxPc3
cells grown in standard medium were immunoprecipitated with
antibodies against E-cadherin, b-catenin and FGFR-1, and the
immunoblots were probed with either anti-E-cadherin or anti-
FGFR-1 antibodies. As shown in Figure 6A, E-cadherin was
detected as a faint band in FGFR-1 immunoprecipitates. In the
reciprocal experiments, these immunoprecipitates were probed
with anti-FGFR-1 antibody. As shown in Figure 6B, FGFR-1 co-
migrated with E-cadherin immunoprecipitates as a fainter signal
(lane 2), and with b-catenin (lane 3). In similar experiments, no
association was detected between FGFR-1 and either a-catenin or
g-catenin (data not shown). These findings suggest that the associ-
ation of FGFR-1 with the E-cadherin/catenin system in BxPc3
cells may primarily involve b-catenin. 
In the second set of experiments, BxPc3 cells were serum-
starved, and then stimulated with FGF-2 (50 ng/ml) for 24 h. Cell
extracts were immunoprecipitated with anti-E-cadherin and anti-
FGFR-1 antibodies, and the immunoblots were probed with anti-
E-cadherin antibody. As shown in Figure 6C, E-cadherin was
detected in FGFR-1 immunoprecipitates from both FGF-treated
and untreated cell extracts (lanes 1 and 2 respectively).
Furthermore, E-cadherin was markedly increased in FGF-treated
cells (lane 3) as compared to control (lane 4). 
E-cadherin and catenins in pancreatic tumours 1659
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Figure 1 Cell–cell adhesion assay. (A–C) Effect of FGF-1 and FGF-2 on
cell-cell adhesion in BxPc3 (A), T3M4 (B) and HPAF cells (C). Cells were
harvested from confluent monolayer cultures by EDTA and suspended in
PBS (Ca2+-free), RPMI medium (2 mM Ca2+) or treated with 10 ng/ml FGF-1
and FGF-2 (added to RPM1/0.8% FCS). The accumulation of cell aggregates
was determined at times 0, 15, 30, 45 and 60 min using a Coulter counter.
The time to half-maximal aggregation is indicated by arrows. (D) Blocking of
cell-cell adhesion on addition of anti-E-cadherin (HECD-1) antibody to FGF-
treated or untreated (control) T3M4 cells 30 min before initiation of the assay.
(E) Effect of FGF-1 and FGF-2 on cell-cell adhesion as a function of dose (1,
5, 10, 20 and 50 ng/ml) in HPAF cells. The accumulation of aggregates was
determined after 30 min. #, P < 0.01; *, P < 0.001. All experiments were
carried out in duplicate and the results represent the means ± SD of at least
six separate experiments
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DISCUSSION 
Increasing evidence suggests that changes in the expression levels
and/or functional state of RTK and E-cadherin may be related
cellular events that are associated with tumour progression
(Hoschuetzky et al, 1994; Kanai et al, 1995). The potential
involvement of the FGF/FGFR system in E-cadherin-mediated
functions is less well explored. FGF/FGFR interaction was
reported to modulate the neurite outgrowth function of NCAM
(Williams et al, 1994). Similar to other RTKs, signals mediated by
FGF/FGFR induce a multitude of cellular activities from differen-
tiation to proliferation. These observations prompted us to investi-
gate: (a) the possible involvement of FGF/FGFR in the modulation
of the functional activities of E-cadherin/catenin system, and 
(b) possible molecular interactions between FGFR and the 
E-cadherin/catenin complex. 
Cell lines used in this study displayed adhesive ability that was
Ca2+-dependent and E-cadherin-mediated. Both FGFs modulated
cell-cell adhesion from a sluggish to an accelerated rate and from a
weak to a strong adhesion state. The rapidity of cell adhesion
suggested that FGFs led to a direct activation of E-cadherin
complexes, rather than modulation of expression of E-cadherin. A
possible explanation is that FGFs lead to a rapid relocalisation of
E-cadherin to the plasma membrane and subsequent recruitment of
E-cadherin and catenins into complexes. This view is supported by
our observations that the components of the E-cadherin/catenin
complex partition into plasma-bound and cytosolic pools in these
cell lines (El-Hariry et al, 1999). Additionally, the formation of
large compact aggregates in response to FGFs may suggest
increased coupling of the E-cadherin/catenin system to the actin
cytoskeleton (El-Hariry, unpublished data) and subsequent
increase in E-cadherin adhesive ability. 
These findings add further support to the observations that
various growth factors exert distinct effects on the E-cadherin/-
catenin system. While the adhesive function of E-cadherin/catenin
complex can be restored by insulin-like growth factor I (IGF-I) in
human breast cancer MCF-7/6 cells (Bracke et al, 1993), other
growth factors such as EGF were shown to reduce E-cadherin-
mediated cell-cell adhesion and perturb its association with
cytoskeletal proteins (Hazan and Norton, 1998). 
We also demonstrated that the pancreatic cell lines differed in
their invasive ability, which can be modulated by FGFs. The inva-
sive ability of these cell lines was not suppressed completely in the
presence of FGFs, which emphasizes the fact that other molecular
mechanisms play a role in the invasion process. Modulation of E-
cadherin function was also observed in the presence of insulin-like
growth factor I (IGF-I) (Bracke et al 1991), and tamoxifen (Bracke
et al, 1994). Taken together, FGFs could be added to the growing
list of factors that lead to the modification of E-cadherin functions. 
An interesting finding in the present study was the induction of
differentiation in the HPAF cell line. FGFs are known for their
pleiotropic effects in vivo that include mitogenic, migratory and
differentiation responses (Roghani and Moscatelli, 1992). FGFs
may induce a morphogenic process through augmentation of cell-
cell and/or cell-stromal interactions. In this regard, FGF-2 has
been shown not only to upregulate many integrin receptors in vitro
and in vivo, but also potentiate their adhesive and signalling func-
tions (Kinoshita et al, 1993; Miyamoto et al, 1996). Interestingly,
cross-talk has recently been reported between E-cadherin and
a2b1 integrin (Pignatelli et al, 1997); the latter plays an essential
role in epithelial renewal and promotes terminal differentiation of
cultured keratinocytes (Watt and Hertle, 1994). The cell surface
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Figure 2 Effect of FGF-1 and FGF-2 on the invasive behaviour into
collagen gel. Collagen gels were freshly prepared (see material and
methods), and 1 ´ 105 cells re-suspended in 1 ml of RPM1/1% FCS (control)
or supplemented with FGF-1 or FGF-2 (1, 5, 10, 20 ng/ml) were seeded onto
the gel. The assay was maintained for 10 days. Gels were then fixed in 10%
formaldehyde overnight, paraffin embedded, serially sectioned, and stained
with haematoxylin and eosin. The degree of invasion was represented by the
invasion index (Nv/Nc), where Nv is the number of invading cells in
stimulated cultures and Nc is the number of invading cells in control culture.
These results represent the mean ± SD of three independent experiments
A B C
Figure 3 Morphogenic effect of FGFs on HPAF cells in 3-D collagen gel. Single cell suspension was mixed with neutralised vitrogen solution (1 ´ 105 cells/ml).
Cells were fed with standard medium alone (A) or supplemented with (B) FGF-1 (10 ng/ml) or (C) FGF-2 (10 ng/ml), that was replaced every 4 days for 21
days. Experiments were carried out in duplicate and repeated twiceE-cadherin and catenins in pancreatic tumours 1661
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proteoglycans – in addition to their role in FGF/FGFR system acti-
vation – appear to play an important role in maintaining the epithe-
lial phenotype and modulating the expression of E-cadherin and
integrins (Day et al, 1999; Kato et al, 1995; Leppa et al, 1996).
Taken together, the FGF/FGFR system may influence the differen-
tiation process by regulating the coordinated activities of both cell-
cell and cell-matrix machinery. 
The present findings are in contrast to the reports suggesting that
overexpression of FGFs and FGFRs may be associated with short
survival of patients with pancreatic adenocarcinoma (Ohta et al,
1995; Yamanaka et al, 1993). However, it is difficult to draw a firm
conclusion in the light of the following observations. The studies to
date have included a relatively small number of patients, and it is
important to match cases carefully for other factors contributing to
survival. Importantly, these studies have shown a correlation
between FGF-1 or FGF-2 (with or without coexpression of FGFR)
and advanced stage, in no case was the overexpression of FGF
and/or FGFR an independent prognostic factor for survival. The
nuclear localization of a high molecular weight form of FGF-2 in
these studies may also suggest differential effects of FGF-2 in the
milieu of the tumour microenvironment. Interestingly, paradoxical
findings have been observed in other systems (Blanckaert et al,
1998; McLeskey et al, 1994; Smith et al, 1999; Wang et al, 1997). 
The potential involvement of FGF/FGFR in E-cadherin-medi-
ated functions is less well explored. In contrast to our findings,
FGF-1 has been found to induce a dysfunctional state of E-
cadherin in a rat bladder cell line (Boyer et al, 1992). However, a
role for the FGF/FGFR system in the modulation of cell-cell adhe-
sion, invasion and morphogenesis is supported by observations in
other systems. The expression of dominant-negative FGFR in
PCI2 neuronal cells prevents neurite outgrowth in response to L1,
N-CAM or N-cadherin (Saffel et al, 1997). In a recent report,
FGF-2 completely inhibited colony formation in soft agar in SK-
N-MC cell lines via binding to FGFR, and resulted in the acquisi-
tion of a less transformed and more differentiated phenotype (van
Puijenbroek et al, 1997). 
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The FGFs-induced effects on E-cadherin/catenin function(s)
may suggest a post-translational mechanism via modulation of the
phosphorylation/dephosphorylation state of one or more compo-
nents of the cadherin/catenin system. Increased tyrosine phospho-
rylation of catenins has previously been correlated with the
abrogation of cell-cell adhesion (Behrens et al, 1993). Recently
however, it has been reported that in primary mouse keratinocytes,
b-catenin, g-catenin and p120ctn become phosphorylated at tyrosine
residues upon induction of differentiation with Ca2+ treatment
(Calautti et al, 1998). These observations suggest that post-
translational modification of the E-cadherin system may be cell-type
or system-dependent, and hence warrants further investigation.
We have demonstrated a physical association between FGFR-1
and the E-cadherin/catenin system in pancreatic cancer cells.
Interestingly, the data suggest that the interaction may primarily
involve association between FGFR-1 and b-catenin. Other RTK
such as erb-B2 and EGFR have been reported to associate with E-
cadherin/catenin system (Hoschuetzky et al, 1994; Kanai et al,
1995). It is possible that FGFR-E-cadherin/catenin interaction
facilitates the functional cross-talk between the two systems, and
exerts positive regulatory cues as opposed to the negative effects
of EGFR. 
ACKNOWLEDGEMENTS 
This work was supported by the Imperial Cancer Research Fund
and a Paolo Baffi fellowship (to I. EI-H) from the Fondazione per
la Formazione Oncologica (Milan, Italy). The authors thank Dr
Helen Hurst for critical reading of the manuscript. 
REFERENCES 
Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier
W (1993) Loss of epithelial differentiation and gain of invasiveness correlates
with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells
transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:
757–766 
Birchmeier W, Weidner KM and Behrens J (1993) Molecular mechanisms leading to
loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci
Suppl 17: 159–164 
Blanckaert VD, Hebbar M, Louchez MM, Vilain MO, Schelling ME and Peyrat JP
(1998) Basic fibroblast growth factor receptors and their prognostic value in
human breast cancer. Clinical Cancer Research 4: 2939–2947 
Boyer B, Dufour S and Thiery JP (1992) E-cadherin expression during the acidic
FGF-induced dispersion of a rat bladder carcinoma cell line. Exp Cell Res 201:
347–357 
Bracke ME, Van Larebeke NA, Vyncke BM and Mareel MM (1991) Retinoic acid
modulates both invasion and plasma membrane ruffling of MCF-7 human
mammary carcinoma cells in vitro. Br J Cancer 63: 867–872 
Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van
Larebeke NA, Vleminckx K, Van Roy FM and Mareel MM (1993) Insulin-like
growth factor I activates the invasion suppressor function of E-cadherin in
MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 68: 282–289 
Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM and Castronovo V
(1994) Tamoxifen restores the E-cadherin function in human breast cancer
MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res 54:
4607–4609 
Byers S, Amaya E, Munro S and Blaschuk O (1992) Fibroblast growth factor
receptors contain a conserved HAV region common to cadherins and influenza
Table 1 Effect of FGF-1 and FGF-2 on the expression of E-cadherin and
catenins 
Cell lines BxPc3 T3M4 HPAF 
FGF-1 FGF-2 FGF-1 FGF-2 FGF-1 FGF-2
E-cadherin
Expression + + +/– +/– + + 
Localization NC NC M/C®M 
a-catenin
Expression – – – – – – 
Localization NC NC NC 
b-catenin
Expression +/– +/– – – +/– + 
Localization NC NC M/C®M 
g-catenin
Expression + + –/+ – +/– + 
Localization NC NC NC 
An avidin-biotin-peroxidase technique was applied. An arbitrary scale was
used to evaluate the expression level: -, no difference in expression level
compared to untreated cells; +/–, expression is equivocal; and +, increased
expression. M/C: mixed membranous and cytoplasmic expression; M:
membranous; NC: no change. 
IP
Anti-FGFR-1
Anti-E-cadherin
Anti-b-catenin
IgG
A
B
C
120 kD
Blot
Anti-E-cadherin
110 kD
Blot
Anti-FGFR-1
Blot Anti-E-cadherin
1234
IP
Anti-FGFR-1
Anti-E-cadherin
IgG
FGF-2 + - + -
12345
120 kD
Figure 6 (A and B) Cell extracts from B´Pc3 cell line were
immunoprecipitated with anti-FGFR-1 (lane 1), anti-E-cadherin (lane 2), anti-
b-catenin (lane 3) antibodies, resolved on 8% polyacrylamide gel, and
proteins were transferred onto nitrocellulose membrane. Membranes were
then probed with either anti-E-cadherin (A) or anti-FGFR-1 (B) antibodies.
Immunoprecipitates with mouse IgG anti-serum were used as controls for
antibody reactivity (lane 4). (C) Serum-starved B´Pc3 cells were stimulated
with 50 ng/ml FGF-2 for 24 h, and equal aliquots of cell extracts were
immunoprecipitated with anti-FGFR-1 (lanes 1 and 2) or anti-E-cadherin
(lanes 3 and 4) antibodies. Proteins were separated by SDS-PAGE,
transferred onto nitrocellulose membranes, and probed with anti-E-cadherin
antibody. Immunoprecipitates with mouse IgG anti-serum were used as
controls for antibody reactivity (lane 5). Molecular mass markers are
indicated by arrowsE-cadherin and catenins in pancreatic tumours 1663
British Journal of Cancer (2001) 84(12), 1656–1663 © 2001 Cancer Research Campaign
strain A hemagglutinins: a role in protein-protein interactions? Dev Biol 152:
411–414 
Calautti E, Cabodi S, Stein PL, Hatzfeld M, Kedersha N and Paolo Dotto G (1998)
Tyrosine phosphorylation and src family kinases control keratinocyte cell-cell
adhesion. J Cell Biol 141: 1449–1465 
Day RM, Hao X, Ilyas M, Daszak P, Talbot IC and Forbes A (1999) Changes in the
expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.
Virchows Archiv 434: 121–125 
Doherty P, Williams E and Walsh FS (1995) A soluble chimeric form of the L1
glycoprotein stimulates neurite outgrowth. Neuron 14: 57–66 
El-Hariry I, Jordinson M, Lemoine N and Pignatelli M (1999) Characterization of
the E-cadherin-catenin complexes in pancreatic carcinoma cell lines. J Pathol
188: 155–162 
Hazan RB and Norton L (1998) The epidermal growth factor receptor modulates the
interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273:
9078–9084 
Hoschuetzky H, Aberle H and Kemler R (1994) Beta-catenin mediates the
interaction of the cadherin-catenin complex with epidermal growth factor
receptor. J Cell Biol 127: 1375–1380 
Kanai Y, Ochiai A, Shibata T, Oyama T, Ushijima S, Akimoto S and Hirohashi S
(1995) c-erbB-2 gene product directly associates with beta-catenin and
plakoglobin. Biochem Biophys Res Commun 208: 1067–1072 
Kato M, Saunders S, Nguyen H and Bernfield M (1995) Loss of cell surface
syndecan-1 causes epithelia to transform into anchorage-independent
mesenchyme-like cells. Mol Biol Cell 6: 559–576 
Kinoshita Y, Kinoshita C, Heuer JG and Bothwell M (1993) Basic fibroblast growth
factor promotes adhesive interactions of neuroepithelial cells from chick neural
tube with extracellular matrix proteins in culture. Development 119: 943–956 
Leppa S, Vleminckx K, Van Roy F and Jalkanen M (1996) Syndecan-1 expression in
mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci 109:
1393–1403 
Leung HY, Gullick WJ and Lemoine NR (1994) Expression and functional activity
of fibroblast growth factors and their receptors in human pancreatic cancer. Int
J Cancer 59: 667–675 
Liu D, Nigam AK, Lalani E-N, Stamp GWH and Pignatelli M (1993) Transfection
of E-cadherin into a human colon carcinoma cell line induces differentiation
and inhibits growth in vitro. Gut 34: 27 
McLeskey SW, Ding IY, Lippman ME and Kern FG (1994) MDA-MB-134 breast
carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are
growth-inhibited by FGF ligands. Cancer Res 54: 523–530 
Metzgar RS, Gaillard MT, Levin SJ, Tuck FL, Bosen EH and Borowitz MJ (1982)
Antigens of human pancreatic adenocarcinoma defined by murine monoclonal
antibodies. Cancer Res 42: 601–608 
Miyamoto S, Teramoto H, Gutkind JS and Yamada KM (1996) Integrins can
collaborate with growth factors for phosphorylation of receptor tyrosine kinases
and MAP kinase activation: roles of integrin aggregation and occupancy of
receptors. J Cell Biol 135: 1633–1642 
Ohta T, Yamamoto M, Numata M, Iseki S, Tsukioka Y, Miyashita T, Kayahara M,
Nagakawa T, Miyazaki I, Nishikawa K and Yoshitake Y (1995) Expression of
basic fibroblast growth factor and its receptor in human pancreatic carcinomas.
Br J Cancer 72: 824–831 
Okabe T, Yamaguchi N and Ohsawa N (1983) Establishment and characterisation of
a carcinoembryonic antigen (CEA)-producing cell line from a human
carcinoma of the exocrine pancreas. Cancer 51: 662–668 
Pignatelli M, Liu D, Nasim MM, Stamp GW, Hirano S and Takeichi M (1992)
Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal
tumour cells. Br J Cancer 66: 629–634 
Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G and
Lemoine NR (1994) Loss of membranous E-cadherin expression in pancreatic
cancer: correlation with lymph node metastasis, high grade, and advanced
stage. J Pathol 174: 243–248 
Pignatelli M, Karayiannakis AJ, Noda M, Efstathiou J and Kmiot WA (1997) E-
cadherin-catenin complex in the gastrointestinal tract. In: The Gut as a Model
in Cell and Molecular Biology, Halter F, Winton D and Wright NA (eds) pp.
194–203. Kluwer: place of publication. 
Roghani M and Moscatelli D (1992) Basic fibroblast growth factor is internalized
through both receptor-mediated and heparan sulfate-mediated mechanisms. J
Biol Chem 267: 22156–22162 
Saffell JL, Williams EJ, Mason IJ, Walsh FS and Doherty P (1997) Expression of a
dominant negative FGF receptor inhibits axonal growth and FGF receptor
phosphorylation stimulated by CAMs. Neuron 18: 231–242 
Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J and Harris AL
(1999) Upregulation of basic fibroblast growth factor in breast carcinoma and
its relationship to vascular density, oestrogen receptor, epidermal growth factor
receptor and survival. Ann Oncol 10: 707–713 
Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator.
Science 251: 1451–1455 
Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian
R, Douglass HO Jr and Chu TM (1986) Characterization of a new primary
human pancreatic tumor line. Cancer Invest 4: 15–23 
van Puijenbroek AA, van Weering DH, van den Brink CE, Bos JL, van der Saag PT, de
Laat SW and den Hertog J (1997) Cell scattering of SK-N-MC neuroepithelioma
cells in response to Ret and FGF receptor tyrosine kinase activation is correlated
with sustained ERK2 activation. Oncogene 14: 1147–1157 
Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yahalom J and Wieder R
(1997) Basic fibroblast growth factor causes growth arrest in MCF-7 human
breast cancer cells while inducing both mitogenic and inhibitory G1 events.
Cancer Res 57: 1750–1757 
Watt F and Hertle M (1994) Keratinocyte integrins. In: The keratinocyte handbook,
Leigh I, Lane B and Watt F (eds) pp 153–164. Cambridge University Press:
Cambridge 
Williams EJ, Furness J, Walsh FS and Doherty P (1994) Activation of the FGF
receptor underlies neurite outgrowth stimulated by L1, N-CAM and N-
cadherin. Neuron 13: 583–594 
Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS and
Korc M (1993) Overexpression of acidic and basic fibroblast growth factors in
human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53:
5289–5296 